Animal ID:
RB1835-1836
|
Host:
Rabbit
|
Reactivity:
human
|
Buffers:
Purified rabbit polyclonal antibody supplied in PBS with 0.09% (W/V)
sodium azide. This antibody is purified through a protein G column and
eluted out with both high and low pH buffers and neutralized immediately
after elution then followed by dialysis against PBS.
|
Storage:
Maintain refrigerated at 2-8ºC for up to 6 months. For long term storage
store at -20ºC. Avoid repeated freeze-thaw cycles.
|
Application:
Tested by peptide-specific ELISA (1:1,000).
|
|
Immunogen:
KLH conjugated synthetic peptide comprised of amino acids 1553 - 1568
[SASRWKASKYYLDLNC] of the human low-density lipoprotein receptor-related
protein 5 (LRP5) protein. |
Accession number:
NM_002335 |
Description:
Low-density lipoprotein receptor-related protein 5 (LRP5) is a
member of the low density lipoprotein receptor (LDLR) family which
consists of cell surface proteins involved in receptor-mediated
endocytosis of specific ligands. LRP5 cause several human diseases,
including
bone mineral density variability 1
endosteal hyperostosis,
autosomal dominant osteopetrosis type I,
osteoporosis-pseudoglioma syndrome and
van Buchem disease type 2. The V171 mutation in LRP5 causes high
bone density by impairing the action of a normal antagonist of the Wnt
pathway and thus increasing Wnt signaling. |
Alternative Name(s):
low density lipoprotein receptor-related protein 5, HBM, LR3, LRP7,
OPPG, BMND1, low density lipoprotein receptor-related protein 7 |
References:
-
Van Hul E, Gram J, Bollerslev J, Van Wesenbeeck L, Mathysen D,
Andersen PE, Vanhoenacker F, Van Hul W: Localization of the gene
causing autosomal dominant osteopetrosis type I to chromosome
11q12-13. J. Bone Miner. Res. 17(6): 1111-1117 (2002).
-
Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D,
Insogna K, Lifton RP: High bone density due to a mutation in
LDL-receptor-related protein 5. N. Engl. J. Med. 346(20):
1513-1521 (2002).
-
Okubo M, Horinishi A, Kim DH, Yamamoto TT, Murase T: Seven novel
sequence variants in the human low density lipoprotein receptor
related protein 5 (LRP5) gene. Hum. Mutat. 19(2): 186 (2002).
-
Little RD, Carulli JP, Del Mastro RG, Dupuis J, Osborne M, Folz C,
Manning SP, Swain PM, Zhao SC, Eustace B, Lappe MM, Spitzer L,
Zweier S, Braunschweiger K, Benchekroun Y, Hu X, Adair R, Chee L,
FitzGerald MG, Tulig C, Caruso A, Tzellas N, Bawa A, Franklin B,
McGuire S, Nogues X, Gong G, Allen KM, Anisowicz A, Morales AJ,
Lomedico PT, Recker SM, Van Eerdewegh P, Recker RR, Johnson ML:
A mutation in the LDL receptor-related protein 5 gene results in the
autosomal dominant high-bone-mass trait. Am. J. Hum. Genet.
70(1): 11-19 (2002).
-
Chen D, Lathrop W, Dong Y: Molecular cloning of mouse Lrp7(Lr3)
cDNA and chromosomal mapping of orthologous genes in mouse and
human.
Genomics 55(3): 314-321 (1999).
-
Dong Y, Lathrop W, Weaver D, Qiu Q, Cini J, Bertolini D, Chen D:
Molecular cloning and characterization of LR3, a novel LDL receptor
family protein with mitogenic activity. Biochem. Biophys. Res.
Commun. 251(3): 784-790 (1998).
-
Hey PJ, Twells RC, Phillips MS, Yusuke Nakagawa, Brown SD, Kawaguchi
Y, Cox R, Guochun Xie, Dugan V, Hammond H, Metzker ML, Todd JA, Hess
JF: Cloning of a novel member of the low-density lipoprotein
receptor family. Gene 216(1): 103-111 (1998).
|
|
+32 1658 9045
+32 1650 9045
